TCL Archive NCAB To Consider Fate Of Existing Two Proposed Comp Center At Important Meeting April 28, 1978
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012